Lantern Pharma Inc.

Lantern Pharma Inc. - PE Ratioverified

LTRN

Price:

$3.79

Market Cap:

$48.36M

Lantern Pharma Inc. is a clinical-stage biotechnology firm dedicated to revolutionizing drug development through the strategic application of artificial intelligence, machine learning, and comprehensive genomic data analysis. Their primary drug candidate, LP-100, is currently undergoing Phase II clinical trials, targeting metastatic, castration-resistant prostate cancer. The company is also advancing LP-300 as a potential combination therapy for non-small cell lung cancer adenocarcinoma, specifically in individuals who are non-smokers or have never smoked. Furthermore, their preclinical pipeline includes LP-184, an alkylating agent engineered to inflict DNA damage upon cancer cells that eith...[Read more]

Industry

Biotechnology

IPO Date

2020-06-11

Stock Exchange

NASDAQ

Ticker

LTRN

The PE Ratio as of June 2026 (TTM) for Lantern Pharma Inc. (LTRN) is -2.61

According to Lantern Pharma Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -2.61. This represents a change of 30.35% compared to the average of -2.00 of the last 4 quarters.

Lantern Pharma Inc. (LTRN) Historical PE Ratio (quarterly & annually)

How has LTRN PE Ratio performed in the past?

The mean historical PE Ratio of Lantern Pharma Inc. over the last ten years is -16.06. The current -2.61 PE Ratio has changed 1.52% with respect to the historical average. Over the past ten years (40 quarters), LTRN's PE Ratio was at its highest in in the March 2026 quarter at -1.14. The PE Ratio was at its lowest in in the March 2019 quarter at -51.20.

Quarterly (TTM)
Annual

Average

-16.06

Median

-5.84

Minimum

-53.39

Maximum

-0.00

Lantern Pharma Inc. (LTRN) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Lantern Pharma Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 116.72%

Maximum Annual PE Ratio = -0.00

Minimum Annual Increase = -99.94%

Minimum Annual PE Ratio = -53.39

Quarterly (TTM)
Annual
YearPE RatioChange
2025-1.93116.72%
2024-0.00-99.94%
2023-2.91-36.85%
2022-4.61-34.71%
2021-7.06-65.15%
2020-20.26-47.14%
2019-38.33-28.21%

Lantern Pharma Inc. (LTRN) Average PE Ratio

How has LTRN PE Ratio performed in the past?

The current PE Ratio of Lantern Pharma Inc. (LTRN) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-1.61

5-year avg

-3.30

10-year avg

-16.06

Lantern Pharma Inc. (LTRN) PE Ratio vs. Peers

How is LTRN’s PE Ratio compared to its peers?

Lantern Pharma Inc.’s PE Ratio is less than Elutia Inc. (0.85), less than Tvardi Therapeutics, Inc. (-1.65), less than CalciMedica, Inc. (-0.57), less than MAIA Biotechnology, Inc. (-2.05), less than LAVA Therapeutics N.V. (-2.01), greater than RenovoRx, Inc. (-2.74), less than Reviva Pharmaceuticals Holdings, Inc. (-0.26), less than Actinium Pharmaceuticals, Inc. (-1.37), less than Annovis Bio, Inc. (-1.02), less than BioAtla, Inc. (-0.09),

Build a custom stock screener for Lantern Pharma Inc. (LTRN) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Lantern Pharma Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Lantern Pharma Inc. (LTRN) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Lantern Pharma Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Lantern Pharma Inc.'s PE Ratio?

How is the PE Ratio calculated for Lantern Pharma Inc. (LTRN)?

What is the highest PE Ratio for Lantern Pharma Inc. (LTRN)?

What is the 3-year average PE Ratio for Lantern Pharma Inc. (LTRN)?

What is the 5-year average PE Ratio for Lantern Pharma Inc. (LTRN)?

How does the current PE Ratio for Lantern Pharma Inc. (LTRN) compare to its historical average?